20/20 Biolabs, Inc. (AIDX) Revenue (2025 - 2026)
20 (AIDX) posted Revenue of $353375.0 for Q1 2026, down 36.19% quarter-over-quarter from $553820.0 in Q1 2025, and down 36.19% year-on-year from $553820.0 in Q1 2025.
20/20 Biolabs, Inc. (AIDX) Revenue (2025 - 2026) Analysis & Trends
20 (AIDX) has reported Revenue for 2 consecutive years, with $353375.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,375.00 |
| Mar 31, 2025 | 553,820.00 |